Fluconazole‐resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole‐resistance profiles associated with the Y132F ERG11p substitution
Mesquida Aina; Alcoceba Eva; Padilla Eduardo; Ramírez Aída; Merino Paloma; González‐Romo Fernando; De Carolis Elena; Sanguinetti Maurizio; Mantecón‐Vallejo María de los Ángeles; Muñoz‐Algarra María; Durán‐Valle Teresa; Pérez‐Ayala Ana; Gómez‐García‐de‐la‐Pedrosa Elia; del Carmen Martínez‐Jiménez María; Sánchez‐Castellano Miguel Ángel; Quiles‐Melero Inmaculada; Cuétara María Soledad; Sánchez‐García Aída; Muñoz Patricia; Escribano Pilar; Guinea Jesús
Abstract:
AbstractBackgroundFluconazole‐resistant Candida parapsilosis is a matter of concern.ObjectivesTo describe fluconazole‐resistant C. parapsilosis genotypes circulating across hospitals in Spain and Rome and to study their azole‐resistance profile associated with ERG11p substitutions.Patients/MethodsWe selected fluconazole‐resistant C. parapsilosis isolates (n = 528 from 2019 to 2023; MIC ≥8 mg/L according to EUCAST) from patients admitted to 13 hospitals located in five Spanish cities and Rome. Additionally, we tested voriconazole, posaconazole, isavuconazole, amphotericin B, micafungin, anidulafungin and ibrexafungerp susceptibility.ResultsOf the 53 genotypes found, 49 harboured the Y132F substitution, five of which were dominating city‐specific genotypes involving almost half the isolates. Another genotype involved isolates harbouring the G458S substitution. Finally, we found two genotypes with the wild‐type ERG11 gene sequence and one with the R398I substitution. All isolates were fully susceptible/wild‐type to amphotericin B, anidulafungin, micafungin and ibrexafungerp. The azole‐resistance patterns found were: voriconazole‐resistant (74.1%) or voriconazole‐intermediate (25.2%), posaconazole‐resistant (10%) and isavuconazole non‐wild‐type (47.5%). Fluconazole‐resistant and voriconazole non‐wild‐type isolates were likely to harbour substitution Y132F if posaconazole was wild type; however, if posaconazole was non‐wild type, substitution G458S was indicated if isavuconazole MIC was >0.125 mg/L or substitution Y132F if isavuconazole MIC was ≤0.125 mg/L.ConclusionsWe detected a recent clonal spread of fluconazole‐resistant C. parapsilosis across some cities in Spain, mostly driven by dominating city‐specific genotypes, which involved a large number of isolates harbouring the Y132F ERG11p substitution. Isolates harbouring substitution Y132F can be suspected because they are non‐susceptible to voriconazole and rarely posaconazole‐resistant.
Mycoses: 2024
doi: 10.1111/myc.13706
https://doi.org/doi: 10.1111/myc.13706
